Home › Pagkabigo ng Puso › Texas › Austin
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Austin, TX
Isang pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Alleviant ALLAY-HFrEF Study
Nagre-recruit
- Austin Heart, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
- Austin Heart, Austin
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Austin
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Nagre-recruitPhase 3
- Austin, TX Investigative Site 10015, Austin
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Nagre-recruitPhase 3
- CON-10015 Austin, TX Investigational Site, Austin
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Nagre-recruitObservasyonal na pag-aaral
- Texas Cardiac Arrhythmia Research Foundation, Austin
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Dell Children's Medical Center of Central Texas, Austin
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Nagre-recruitObservasyonal na pag-aaral
- Austin, Austin
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Nagre-recruitPhase 3
- Tenax Investigational Site, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- Austin Heart, Austin
Alleviant ALLAY-HF Study
Nagre-recruit
- Austin Heart, Austin
Assessment of CCM in HF With Higher Ejection Fraction
Nagre-recruit
- Ascension Seton, Austin
- Austin Heart, Austin
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Nagre-recruitPhase 3
- FIN-10015 Austin, TX Investigational Site, Austin
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Nagre-recruit
- Austin Heart, Austin
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Nagre-recruit
- Ascension Texas Cardiovascular, Austin
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Texas Cardiac Arrhythmia Research Foundation, Austin
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
Nagre-recruit
- The University of Texas Austin, Austin
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Nagre-recruitObservasyonal na pag-aaral
- Austin Heart, Austin
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY50 pag-aaral
- Boston, MA43 pag-aaral
- Dallas, TX43 pag-aaral
- Houston, TX36 pag-aaral
- Cleveland, OH33 pag-aaral
- Chicago, IL32 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- Durham, NC26 pag-aaral
- St. Louis, MO26 pag-aaral
- Kansas City, MO25 pag-aaral
- Atlanta, GA25 pag-aaral
Iba pang pag-aaral sa Austin
- Non-Small Cell Lung Cancer30 pag-aaral
- Kanser (lahat ng uri)21 pag-aaral
- Obesity21 pag-aaral
- Overweight19 pag-aaral
- Metastatic Cancer19 pag-aaral
- Colorectal Cancer19 pag-aaral
- Kanser sa Suso18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Depression15 pag-aaral
- Triple-Negative Breast Cancer13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.